tiprankstipranks

Nancy Simonian Insider Profile

4 Followers
Nancy Simonian, Director at Seagen, holds 131.66K shares in Syros Pharmaceuticals (Ticker: SYRS), holds 0.00 shares in Seagen (Ticker: SGEN), holds ― shares in Evelo Biosciences (Ticker: EVLO).
tipranks
Nancy Simonian

Nancy Simonian
Seagen (SGEN)
Director

Ranked #16,641 out of 98,624 Corporate Insiders

Profitable Transactions

60%
3 out of 5 Profitable Transactions

Average Return

+20.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$664K
100.00%
0.00%
A breakdown of Nancy Simonian's holdings

Insider Roles

Syros Pharmaceuticals
(SYRS)
Director
Evelo Biosciences
(EVLO)
Director
Roles that Nancy Simonian holds in companies

Most Profitable Insider Trade

Stock:
Syros Pharmaceuticals
(SYRS)
Rating:Informative Buy
Date:Dec 23, 2019 - Dec 23, 2020
Return:+101.30%
The most profitable trade made by Nancy Simonian

Nancy Simonian's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
SGEN
Seagen
Dec 15, 2023
Uninformative Sell
14.37M
$0.00
Syros Pharmaceuticals
Apr 02, 2024
Director
Uninformative Buy
71.95K
$663.56K
Evelo Biosciences
Director
ARQL
Arqule
$0.00
List of latest transactions for each holding click on a transaction to see Nancy Simonian's performance on stock

Nancy Simonian insider profile FAQ

What is the percentage of profitable transactions made by Nancy Simonian?
The percentage of profitable transactions made by Nancy Simonian is 60%.
    What is the average return per transaction made by Nancy Simonian?
    The average return per transaction made by Nancy Simonian is 20.60%.
      What stocks does Nancy Simonian hold?
      Nancy Simonian holds: SGEN, SYRS, EVLO, ARQL stocks.
        What was Nancy Simonian’s latest transaction?
        Nancy Simonian latest transaction was an Uninformative Buy of $71.95K.
          What was Nancy Simonian's most profitable transaction?
          Nancy Simonian’s most profitable transaction was an Informative Buy of SYRS stock on December 23, 2019. The return on the trade was 101.30%.
            What is Nancy Simonian's role in Seagen?
            Nancy Simonian's role in Seagen is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.